Physician profile
Elizabeth Marie Cullen
NPI 1174506414
$288,739.44
in general payments reported to CMS, 2019-2025
14 companies · $121K in 2025
The $121K reported for 2025 was more than what 99% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $22K · 2021: $27K · 2022: $31K · 2023: $34K · 2024: $31K · 2025: $121K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $121K · Royalty Or License: $65K · Food and Beverage: $86.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $120,598.14 |
| Royalty Or License | $64,554.00 |
| Food and Beverage | $86.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pediatric Alliance LLC | $288,331.14 | 2019-2025 | |
| Ipsen Biopharmaceuticals, INC | $100.00 | 2019 | |
| Merck Sharp & Dohme LLC | $62.21 | 2019-2023 | Vaxelis, Gardasil 9, Vaxneuvance |
| Kaleo, INC. | $40.27 | 2019 | |
| Pfizer INC. | $34.23 | 2022-2023 | |
| Biomarin Pharmaceutical INC. | $30.63 | 2022 | |
| Sobi, INC | $24.84 | 2022 | |
| Sanofi Pasteur INC. | $24.80 | 2024 | |
| Shire North American Group INC | $20.33 | 2019 | |
| Alk-Abello, INC | $17.91 | 2025 | Neffy |
| Baxter Healthcare | $16.58 | 2021 | |
| Ironshore Pharmaceuticals INC. | $12.77 | 2019 | |
| Biogen, INC. | $12.41 | 2019 | |
| Cranial Technologies, INC | $11.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$488,693.80 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Cullen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.